Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Rubrik Inc. Class A Common Stock (RBRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Rubrik Inc. Class A Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Rubrik Inc. Class A Common Stock trades at $125.12 (market cap $25.06B). The key difference: Rubrik Inc. Class A Common Stock is the larger of the two by market cap, and Rubrik Inc. Class A Common Stock is more actively traded (2,394,852 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Rubrik Inc. Class A Common Stock for 1 Days on average.
| HALO | RBRK | |
|---|---|---|
Market Cap | $12.58B | $25.06B |
Volume | 2,179,278 | 2,394,852 |
Sector | Health | Technology |
52-Week High | $115.22 | $125.80 |
52-Week Low | $61.63 | $43.81 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $24.46B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Rubrik Inc. Class A Common Stock
Rubrik provides data security and cyber recovery software for enterprises. Its platform protects data across on-premises, cloud, SaaS, and unstructured-data environments.
Read more on RBRK →
